McKesson, the largest U.S. pharmaceutical distributor, continues to face obstacles as the tailwind from branded drug price inflation subsides and customers look elsewhere. But its management isn’t taking the news lying down. A series of acquisitions, ongoing restructuring, and a rash of new deals are helping lessen the blow, setting in motion a roller-coaster ride of a year. McKesson was founded in 1833 and is headquartered in San Francisco.
Looking for leads, investment insights, or competitive intelligence?
News about McKesson
Corporate governance matters, too.
New report highlights revolving door between DEA and industry.
More than 60% of overdose deaths in 2015 were related to opioid drugs.
John Hammergren is one of America's highest-paid executives.
The ruling led a St. Louis judge at J&J's urging to declare a mistrial in the latest talc case.